Dynamic conformational transitions of the EGF receptor in living mammalian cells determined by FRET and fluorescence lifetime imaging microscopy

We have revealed a reorientation of ectodomain I of the epidermal growth factor receptor (EGFR; ErbB1; Her1) in living CHO cells expressing the receptor, upon binding of the native ligand EGF. The state of the unliganded, nonactivated EGFR was compared to that exhibited after ligand addition in the presence of a kinase inhibitor that prevents endocytosis but does not interfere with binding or the ensuing conformational rearrangements. To perform these experiments, we constructed a transgene EGFR with an acyl carrier protein sequence between the signal peptide and the EGFR mature protein sequence. This protein, which behaves similarly to wild‐type EGFR with respect to EGF binding, activation, and internalization, can be labeled at a specific serine in the acyl carrier tag with a fluorophore incorporated into a 4′‐phosphopantetheine (P‐pant) conjugate transferred enzymatically from the corresponding CoA derivative. By measuring Förster resonance energy transfer between a molecule of Atto390 covalently attached to EGFR in this manner and a novel lipid probe NR12S distributed exclusively in the outer leaflet of the plasma membrane, we determined the apparent relative separation of ectodomain I from the membrane under nonactivating and activating conditions. The data indicate that the unliganded domain I of the EGFR receptor is situated much closer to the membrane before EGF addition, supporting the model of a self‐inhibited configuration of the inactive receptor in quiescent cells. © 2013 International Society for Advancement of Cytometry

[1]  J. Ponder,et al.  Force fields for protein simulations. , 2003, Advances in protein chemistry.

[2]  G. Nolan Proteomics and genomics: The emergent properties of biomarkers in mechanism and medicine , 2006 .

[3]  Michael Kofler,et al.  The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. , 2003, Molecular cell.

[4]  T. Jovin,et al.  Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis , 2010, Proceedings of the National Academy of Sciences.

[5]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[6]  E. Wolf,et al.  The epidermal growth factor receptor ligands at a glance , 2009, Journal of cellular physiology.

[7]  P. Bastiaens,et al.  Imaging Phosphorylation Dynamics of the Epidermal Growth Factor Receptor* , 2004, Journal of Biological Chemistry.

[8]  T. Knöchel,et al.  Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization. , 2008, Cancer cell.

[9]  J. Prestegard,et al.  Refinement of the NMR structures for acyl carrier protein with scalar coupling data , 1990, Proteins.

[10]  D. Engelman,et al.  Two EGF molecules contribute additively to stabilization of the EGFR dimer , 1997, The EMBO journal.

[11]  K. Ferguson,et al.  Interaction of antibodies with ErbB receptor extracellular regions. , 2009, Experimental cell research.

[12]  A. Kaye,et al.  The EGFRvIII variant in glioblastoma multiforme , 2009, Journal of Clinical Neuroscience.

[13]  P. Bastiaens,et al.  Prolonged EGFR Signaling by ERBB2‐Mediated Sequestration at the Plasma Membrane , 2008, Traffic.

[14]  Edouard C. Nice,et al.  Ligand-induced Dimer-Tetramer Transition during the Activation of the Cell Surface Epidermal Growth Factor Receptor-A Multidimensional Microscopy Analysis* , 2005, Journal of Biological Chemistry.

[15]  Dennis D Spencer,et al.  Multiphoton fluorescence lifetime imaging of intrinsic fluorescence in human and rat brain tissue reveals spatially distinct NADH binding. , 2008, Optics express.

[16]  P. Sengupta,et al.  Fluorescence resonance energy transfer between lipid probes detects nanoscopic heterogeneity in the plasma membrane of live cells. , 2007, Biophysical journal.

[17]  Elizabeth A Jares-Erijman,et al.  Imaging molecular interactions in living cells by FRET microscopy. , 2006, Current opinion in chemical biology.

[18]  R R Duncan,et al.  Multi‐dimensional time‐correlated single photon counting (TCSPC) fluorescence lifetime imaging microscopy (FLIM) to detect FRET in cells , 2004, Journal of microscopy.

[19]  John Kuriyan,et al.  Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment , 2009, Cell.

[20]  F. Al Dayel EGFR mutation testing in non-small cell lung cancer (NSCLC). , 2012, Journal of infection and public health.

[21]  K. Ferguson,et al.  Structure-based view of epidermal growth factor receptor regulation. , 2008, Annual review of biophysics.

[22]  K. Lidke,et al.  supplementary figures , 2018 .

[23]  Edouard C. Nice,et al.  Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor α , 2002, Cell.

[24]  Shigeyuki Yokoyama,et al.  Structural Evidence for Loose Linkage between Ligand Binding and Kinase Activation in the Epidermal Growth Factor Receptor , 2010, Molecular and Cellular Biology.

[25]  Yves Mély,et al.  Switchable nile red-based probe for cholesterol and lipid order at the outer leaflet of biomembranes. , 2010, Journal of the American Chemical Society.

[26]  Hannes H. Loeffler,et al.  Human Epidermal Growth Factor Receptor (EGFR) Aligned on the Plasma Membrane Adopts Key Features of Drosophila EGFR Asymmetry , 2011, Molecular and Cellular Biology.

[27]  C. Arteaga ERBB receptors in cancer: signaling from the inside , 2011, Breast Cancer Research.

[28]  Derek Toomre,et al.  Spatial control of EGF receptor activation by reversible dimerization on living cells , 2010, Nature.

[29]  R. Tsien,et al.  Partitioning of Lipid-Modified Monomeric GFPs into Membrane Microdomains of Live Cells , 2002, Science.

[30]  A. Burgess,et al.  Evidence for extended YFP-EGFR dimers in the absence of ligand on the surface of living cells , 2011, Physical biology.

[31]  M. Lemmon,et al.  Ligand-induced ErbB receptor dimerization. , 2009, Experimental cell research.

[32]  M. Lemmon,et al.  Finding the missing links in EGFR , 2012, Nature Structural &Molecular Biology.

[33]  N. Johnsson,et al.  Specific labeling of cell surface proteins with chemically diverse compounds. , 2004, Journal of the American Chemical Society.

[34]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[35]  Peter Klein,et al.  On the nature of low- and high-affinity EGF receptors on living cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Jae-Hoon Kim,et al.  Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains , 2002, Cell.

[37]  J. Eisinger,et al.  Resonance energy transfer from a cylindrical distribution of donors to a plane of acceptors. Location of apo-B100 protein on the human low-density lipoprotein particle. , 1990, Biophysical journal.

[38]  M. Martin-Fernandez,et al.  Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling. , 2002, Biophysical journal.

[39]  M. Martin-Fernandez,et al.  Investigating extracellular in situ EGFR structure and conformational changes using FRET microscopy. , 2012, Biochemical Society transactions.

[40]  Y. Mély,et al.  Detection of apoptosis through the lipid order of the outer plasma membrane leaflet. , 2012, Biochimica et biophysica acta.

[41]  K. Ferguson Active and inactive conformations of the epidermal growth factor receptor. , 2004, Biochemical Society transactions.

[42]  L. Stryer,et al.  Surface density determination in membranes by fluorescence energy transfer. , 1978, Biochemistry.

[43]  Forest M White,et al.  Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma , 2007, Proceedings of the National Academy of Sciences.

[44]  M. Lemmon,et al.  Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor , 2010, Cell.

[45]  P. Jeffrey,et al.  Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. , 2005, Cancer cell.

[46]  N. Johnsson,et al.  Multicolor imaging of cell surface proteins. , 2005, Journal of the American Chemical Society.

[47]  E. Elson,et al.  Oligomerization of the EGF receptor investigated by live cell fluorescence intensity distribution analysis. , 2007, Biophysical journal.

[48]  Anton Arkhipov,et al.  Architecture and Membrane Interactions of the EGF Receptor , 2013, Cell.

[49]  Kai Simons,et al.  Regulation of human EGF receptor by lipids , 2011, Proceedings of the National Academy of Sciences.

[50]  Hyun-soo Cho,et al.  EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. , 2003, Molecular cell.